Completed OBSERVATIONAL NCT01157468

Catalytic Antibodies and Lupus in Martinique (LUMAB2)

Study of Catalytic Antibodies in a Cohort Population of Martinique

Sponsor: University Hospital Center of Martinique

Updated 10 times since 2017 Last updated: Sep 7, 2016 Started: Jan 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01157468, this observational or N/A phase trial focuses on Systemic Lupus Erythematosus and remains completed. Sponsored by University Hospital Center of Martinique, it has been updated 10 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Center of Martinique

Data source: University Hospital Center of Martinique

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort de France, France